BEYOND MEAT, INC. (NASDAQ: BYND) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Beyond Meat, Inc. Investors of Upcoming Deadline
globenewswire.com
Want to monitor PDSB?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor PDSBpds biotechnology is a clinical stage biopharmaceutical company developing the next-generation of simpler, safer and more effective immunotherapies for cancer and infectious diseases. pds biotechnology’s proprietary versamune® platform vector is based on synthetic and biodegradable lipids which possess a very specific structure and positive charge. the lipids form nanoparticles which activate and are taken up very efficiently by the immune system.